Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 17/20 | 0.53 |
| ▸ | PDK2 | Q15119 | 17/20 | 0.53 |
| ▸ | PDK3 | Q15120 | 17/20 | 0.53 |
| ▸ | PDK4 | Q16654 | 17/20 | 0.53 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.52 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.48 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.48 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6570088 | 1.00 | PDK1 (0.53) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6570032 | 0.88 | PDK1 (0.60) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6570039 | 0.88 | PDK1 (0.60) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6571054 | 0.85 | ABCB11 (0.72) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6571051 | 0.85 | ABCB11 (0.72) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6571315 | 0.83 | PTGES2 (0.58) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6571322 | 0.83 | PTGES2 (0.58) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6570960 | 0.83 | PDK1 (0.62) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6570966 | 0.83 | PDK1 (0.62) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6569113 | 0.81 | PDK1 (0.59) | PDK1PDK2PDK3PDK4ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1082110-B1 | USE OF COMPOUNDS FOR THE ELEVATION OF PYRUVATE DEHYDROGENASE ACTIVITY | ASTRAZENECA AB (SE) | 2004-03-24 | — | — | EP | disclosed |